Compound Detail
CHEMBL1624
LEVOTHYROXINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1624 |
| Name | LEVOTHYROXINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XUIIKFGFIJCVMT-LBPRGKRZSA-N |
| Therapeutic | ✓ Yes |
11
Targets
18
Activities
3
Assay Types
0
PK Parameters
20
Publications
8
Known Names
8
Indications
Molecular Properties
776.9
MW (Da)
4.56
ALogP
4
HBA
3
HBD
92.8
PSA (Ų)
0.39
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Congenital Hypothyroidism Hypothyroidism Lipid Metabolism Disorders Bipolar Disorder Graves Disease Diabetes Mellitus Infections Pregnancy
Activity Summary
IC50 10 meas. best 5.66
EC50 6 meas. best 7.72
Kd 2 meas. best 6.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Thyroid hormone receptor alpha CHEMBL1860 | EC50 | 7.72 | 7.72 | 19.0 | 1 |
| Thyroid hormone receptor beta CHEMBL1947 | EC50 | 6.62 | 6.62 | 240.0 | 1 |
| Peroxisome proliferator-activated receptor gamma CHEMBL235 | Kd | 6.4 | 6.4 | 400.0 | 1 |
| Retinoic acid receptor RXR-alpha CHEMBL2061 | Kd | 6.03 | 6.03 | 930.0 | 1 |
| Transthyretin CHEMBL3194 | IC50 | 5.66 | 5.49 | 2187.8 | 4 |
| UDP-glucuronosyltransferase 1A1 CHEMBL1287617 | IC50 | 5.31 | 5.28 | 4900.0 | 2 |
| Bile acid receptor CHEMBL2047 | IC50 | 5.11 | 5.11 | 7860.0 | 1 |
| Solute carrier organic anion transporter family member 4C1 CHEMBL2073690 | IC50 | 5.1 | 5.1 | 8000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.98 | 4.98 | 10500.0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 CHEMBL3401 | EC50 | 4.95 | 4.475 | 11200.0 | 2 |
| Peroxisome proliferator-activated receptor gamma CHEMBL235 | EC50 | 4.92 | 4.92 | 12000.0 | 1 |
| Retinoic acid receptor RXR-alpha CHEMBL2061 | EC50 | 4.81 | 4.81 | 15400.0 | 1 |
| Malate dehydrogenase, mitochondrial CHEMBL5917 | IC50 | 4.36 | 4.36 | 43600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 32356658 | 10.1021/acs.jmedchem.9b02150 | Peroxisome proliferator-activated receptor gamma | 13 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 37930268 | 10.1021/acs.jmedchem.3c01026 | ADMET | 10 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20966043 | 10.1124/dmd.110.035105 | Nuclear receptor subfamily 1 group I member 2 | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 32356658 | 10.1021/acs.jmedchem.9b02150 | Retinoic acid receptor RXR-alpha | 4 |
| 19651509 | 10.1016/j.bmcl.2009.03.004 | Transthyretin | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 7381861 | 10.1021/jm00179a024 | Unchecked | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 12871948 | 10.1074/jbc.m300909200 | Monocarboxylate transporter 8 | 3 |
| 32356658 | 10.1021/acs.jmedchem.9b02150 | ADMET | 3 |
| 11561088 | - | Solute carrier organic anion transporter family member 1A3 | 3 |
| 27020050 | 10.1016/j.ejmech.2016.02.074 | Transthyretin | 3 |
| 21030469 | 10.1124/dmd.110.035030 | UDP-glucuronosyltransferase 1A1 | 2 |
| 818381 | 10.1021/jm00227a004 | Rattus norvegicus | 2 |
| 23688559 | 10.1016/j.bmc.2013.04.069 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 3009810 | 10.1021/jm00155a010 | Transthyretin | 2 |
Data from ChEMBL 36 via Core Engine